18 research outputs found
Btk Regulated Macrophage Polarization in Response to Lipopolysaccharide
Bacterial Lipopolysaccharide (LPS) is a strong inducer of inflammation and does so by inducing polarization of macrophages to the classic inflammatory M1 population. Given the role of Btk as a critical signal transducer downstream of TLR4, we investigated its role in M1/M2 induction. In Btk deficient (Btk−\−) mice we observed markedly reduced recruitment of M1 macrophages following intraperitoneal administration of LPS. Ex vivo analysis demonstrated an impaired ability of Btk−/− macrophages to polarize into M1 macrophages, instead showing enhanced induction of immunosuppressive M2-associated markers in response to M1 polarizing stimuli, a finding accompanied by reduced phosphorylation of STAT1 and enhanced STAT6 phosphorylation. In addition to STAT activation, M1 and M2 polarizing signals modulate the expression of inflammatory genes via differential activation of transcription factors and regulatory proteins, including NF-κB and SHIP1. In keeping with a critical role for Btk in macrophage polarization, we observed reduced levels of NF-κB p65 and Akt phosphorylation, as well as reduced induction of the M1 associated marker iNOS in Btk−/− macrophages in response to M1 polarizing stimuli. Additionally enhanced expression of SHIP1, a key negative regulator of macrophage polarisation, was observed in Btk−/− macrophages in response to M2 polarizing stimuli. Employing classic models of allergic M2 inflammation, treatment of Btk−/− mice with either Schistosoma mansoni eggs or chitin resulted in increased recruitment of M2 macrophages and induction of M2-associated genes. This demonstrates an enhanced M2 skew in the absence of Btk, thus promoting the development of allergic inflammation
Attenuated CSF-1R signalling drives cerebrovascular pathology
Cerebrovascular pathologies occur in up to 80% of cases of Alzheimer's disease; however, the underlying mechanisms that lead to perivascular pathology and accompanying blood-brain barrier (BBB) disruption are still not fully understood. We have identified previously unreported mutations in colony stimulating factor-1 receptor (CSF-1R) in an ultra-rare autosomal dominant condition termed adult-onset leucoencephalopathy with axonal spheroids and pigmented glia (ALSP). Cerebrovascular pathologies such as cerebral amyloid angiopathy (CAA) and perivascular p-Tau were some of the primary neuropathological features of this condition. We have identified two families with different dominant acting alleles with variants located in the kinase region of the CSF-1R gene, which confer a lack of kinase activity and signalling. The protein product of this gene acts as the receptor for 2 cognate ligands, namely colony stimulating factor-1 (CSF-1) and interleukin-34 (IL-34). Here, we show that depletion in CSF-1R signalling induces BBB disruption and decreases the phagocytic capacity of peripheral macrophages but not microglia. CSF-1R signalling appears to be critical for macrophage and microglial activation, and macrophage localisation to amyloid appears reduced following the induction of Csf-1r heterozygosity in macrophages. Finally, we show that endothelial/microglial crosstalk and concomitant attenuation of CSF-1R signalling causes re-modelling of BBB-associated tight junctions and suggest that regulating BBB integrity and systemic macrophage recruitment to the brain may be therapeutically relevant in ALSP and other Alzheimer's-like dementias
Nucleic acid cytokine responses in obese children and infants of obese mothers
Almost a third of Irish children are now overweight and the country ranks 58th out of 200 countries for its
proportion of overweight youths. With the rising obesity epidemic, and the impaired immune responses of this
population, it is vital to understand the effects that obesity has on the immune system and to design future
therapeutics, adjuvants and vaccines with overweight and obese populations in mind. Many current vaccines use
adjuvants that have been found to be less effective at stimulating the immune response in children compared
with adults and there is now substantial effort to design paediatric-focused adjuvants. Additionally, vaccine
responses have been shown to be less effective in obese populations indicating that this is a particularly vulnerable population. We have recently identified cytosolic nucleic acids (CNAs), as novel candidate adjuvants for
childhood vaccines. Here we investigated whether immune responses to these candidate adjuvants were adversely affected in infants born to overweight or obese mothers, and in overweight and obese children. Type I
Interferon (IFN) and proinflammatory cytokines such as Tumor Necrosis Factor α (TNFα) are vital for driving
innate and adaptive immune responses. We found that childhood obesity conferred no significant adverse effect
on CNA-induced Type I IFN responses when compared with lean children. Similarly, Type I IFN responses were
intact in the cord blood of babies delivered from overweight and obese mothers, when compared with lean
mothers. There was also no significant impact of obesity on CNA-induced TNFα responses in children or from
cord blood of infants born to overweight/obese mothers. In all cases, there was a tendency towards decreased
production of innate cytokine Type I Interferon and TNFα, however there was no significant negative correlation. Interestingly, high maternal BMI showed weak and moderate positive correlation with IL-12p70 and IFNγ,
respectively, in response to CNA stimulation. This study demonstrates that future adjuvants can be tailored for
these populations through the use of activators of CNA sensors
Btk regulates macrophage polarization in response to lipopolysaccharide
Bacterial Lipopolysaccharide (LPS) is a strong inducer of inflammation and does so by inducing polarization of macrophages to the classic inflammatory M1 population. Given the role of Btk as a critical signal transducer downstream of TLR4, we investigated its role in M1/M2 induction. In Btk deficient (Btk (−\−)) mice we observed markedly reduced recruitment of M1 macrophages following intraperitoneal administration of LPS. Ex vivo analysis demonstrated an impaired ability of Btk(−/−) macrophages to polarize into M1 macrophages, instead showing enhanced induction of immunosuppressive M2-associated markers in response to M1 polarizing stimuli, a finding accompanied by reduced phosphorylation of STAT1 and enhanced STAT6 phosphorylation. In addition to STAT activation, M1 and M2 polarizing signals modulate the expression of inflammatory genes via differential activation of transcription factors and regulatory proteins, including NF-κB and SHIP1. In keeping with a critical role for Btk in macrophage polarization, we observed reduced levels of NF-κB p65 and Akt phosphorylation, as well as reduced induction of the M1 associated marker iNOS in Btk(−/−) macrophages in response to M1 polarizing stimuli. Additionally enhanced expression of SHIP1, a key negative regulator of macrophage polarisation, was observed in Btk(−/−) macrophages in response to M2 polarizing stimuli. Employing classic models of allergic M2 inflammation, treatment of Btk (−/−) mice with either Schistosoma mansoni eggs or chitin resulted in increased recruitment of M2 macrophages and induction of M2-associated genes. This demonstrates an enhanced M2 skew in the absence of Btk, thus promoting the development of allergic inflammation
DataSheet_1_Heightened metabolic responses in NK cells from patients with neuroblastoma suggests increased potential for immunotherapy.pdf
High risk neuroblastoma is responsible for 15% of deaths in pediatric cancer patients. The introduction of anti-GD2 immunotherapy has significantly improved outcomes but there is still only approximately a 50% 5 year event-free-survival for these children and improvements in treatments are urgently required. Anti-GD2 immunotherapy uses the patients’ own immune system to kill cancer cells. In particular, Natural Killer (NK) cells kill antibody coated tumor cells by a process called antibody dependent cellular cytotoxicity (ADCC). However, our previous work has highlighted metabolic exhaustion of NK cells in circulating blood of adult cancer patients, identifying this as a potential therapeutic target. In this study, we investigated circulating NK cells in patients newly diagnosed with neuroblastoma. We found evidence of activation of NK cells in vivo by the cancer itself. While some evidence of NK cell dysfunction was observed in terms of IFNγ production, most results indicated that the NK cell compartment remained relatively intact. In fact, some aspects of metabolic and functional activities were actually increased in patients compared to controls. Glycolytic responses, which we show are crucial for ADCC, were actually enhanced in patients and CD16, the NK cell receptor that mediates ADCC, was also expressed at high levels in some patients. Overall, the data suggest that patient NK cells could be harvested at diagnosis for subsequent beneficial autologous use during immunotherapy. Enhancing glycolytic capacity of cell therapies could also be a strategic goal of future cell therapies for patients with neuroblastoma and indeed other cancers.</p
Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production (vol 183, pg 7703, 2009)
Increased <i>in vivo</i> M2 macrophage generation in the absence of Btk.
<p>(A–C) WT and <i>Btk<sup>−/−</sup></i> mice were injected i.v. with 5,000 live <i>S.mansoni</i> eggs. (A) The percentage of pulmonary M2 macrophages was evaluated by flow cytometry using F4/80 and CD11b co-staining. (B–C) Induction of M2-associated genes was determined by qPCR. (D) WT and <i>Btk<sup>−/−</sup></i> mice were injected i.p. with approximately 800 ng Chitin. Peritoneal cells were collected by lavage after 48 hours and gene induction of M2-associated genes was determined by qPCR. In all cases peritoneal macrophages were pooled after isolation, treatment groups consisted of 3–4 animals, and experiments were performed in triplicate. Student’s paired <i>t</i> test was performed comparing gene induction following <i>in vivo</i> exposure to <i>S.mansoni</i> eggs or Chitin as indicated in WT and Btk<sup>−/−</sup> peritoneal macrophages. Results shown are mean±SD from three independent experiments. * = p≤0.05.</p
Type 1 IFN Induction by Cytosolic Nucleic Acid Is Intact in Neonatal Mononuclear Cells, Contrasting Starkly with Neonatal Hyporesponsiveness to TLR Ligation Due to Independence from Endosome-Mediated IRF3 Activation
Two million infants die each year from infectious diseases before they reach 12 mo; many of these diseases are vaccine preventable in
older populations. Pattern recognition receptors represent the critical front-line defense against pathogens. Evidence suggests that
the innate immune system does not fully develop until puberty, contributing to impaired response to infection and impaired vaccine
responses in neonates, infants, and children. The activity of the pattern recognition receptor family of cytosolic nucleic acid (CNA)
sensors in this pediatric population has not been reported. We show that in direct contrast to weak TLR-induced type I IFN in
human cord blood mononuclear cells, cord blood mononuclear cells are capable of initiating a potent response to CNA, inducing
both antiviral type I IFN and, unexpectedly, proinflammatory TNF-a. A deficiency in Rab11-GTPase endosome formation and
consequent lack of IRF3 activation in neonatal monocytes is at least in part responsible for the marked disparity in TLR-induced
IFN production between neonatal and adult monocytes. CNA receptors do not rely on endosome formation, and therefore, these
responses remain intact in neonates. Heightened neonatal responses to CNA challenge are maintained in children up to 2 y of age
and, in marked contrast to TLR4/9 agonists, result in IL-12p70 and IFN-g generation. CNA sensors induce robust antiviral and
proinflammatory pathways in neonates and children and possess great potential for use as immunostimulants or vaccine adjuvants
for targeted neonatal and pediatric populations to promote cell-mediated immunity against invasive infectious disease
Btk<sup>−/−</sup> macrophages have impaired ability to expand <i>in vitro</i> into M1 cells.
<p>(A–D) Peritoneal macrophages were extracted from WT and <i>Btk<sup>−/−</sup></i> mice and treated <i>ex vivo</i> with an M1 (LPS plus IFN-y) or an M2 (IL-4 plus IL-13) polarizing cocktail for 24 hr and induction of M1 (A–B) and M2- associated (C–D) genes determined by qPCR. In all cases peritoneal macrophages were pooled after isolation, with each treatment group consisting of 3–4 animals, and all experiments were performed in triplicate. Student’s paired <i>t</i> test was performed comparing gene induction in Btk<sup>−/−</sup> peritoneal macrophages to WT cells following treatment with polarizing cocktails as indicated. Results shown are mean±SD from three independent experiments. * = p≤0.05.</p